Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures

被引:4
|
作者
Huo, Chen [1 ]
Zhang, Meng-Yu [1 ]
Li, Rui [1 ]
Liu, Ting-Ting [1 ]
Li, Jian-Ping [1 ]
Qu, Yi-Qing [2 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Pulm & Crit Care Med,Shandong Key Lab Infect, Jinan, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pulm & Crit Care Med, Shandong Key Lab Infect Resp Dis, Jinan, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
关键词
lung adenocarcinoma; glycolysis; tumor mutational burdens; prognosis; tumor-infiltrating immune cell; INTERACTION NETWORKS; CANCER; TUMORS; INHIBITION; RESISTANCE;
D O I
10.3389/fcell.2021.645482
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in large LUAD samples were collected from the Cancer Genome Atlas (TCGA) database. Then, we identified the expression level and prognostic value of glycolysis-related genes, as well as the fractions of 22 immune cells in the tumor microenvironment. The differences between glycolysis activity, mutation, and immune infiltrates were discussed in these groups, respectively. Two hundred fifty-five glycolysis-related genes were identified from gene set enrichment analysis (GSEA), of which 43 genes had prognostic values (p < 0.05). Next, we constructed a glycolysis-related competing endogenous RNA (ceRNA) network which related to the survival of LUAD. Then, two subgroups of LUAD (clusters 1 and 2) were identified by applying unsupervised consensus clustering to 43 glycolysis-related genes. The survival analysis showed that the cluster 1 patients had a worse prognosis (p < 0.001), and upregulated differentially expressed genes (DEGs) are interestingly enriched in malignancy-related biological processes. The differences between the two subgroups are SPTA1, KEAP1, USH2A, and KRAS among top 10 mutated signatures, which may be the underlying mechanism of grouping. Combined high tumor mutational burden (TMB) with tumor subgroups preferably predicts the prognosis of LUAD patients. The CIBERSORT algorithm results revealed that low TMB samples were concerned with increased infiltration level of memory resting CD4+ T cell (p = 0.03), resting mast cells (p = 0.044), and neutrophils (p = 0.002) in cluster 1 and high TMB samples were concerned with increased infiltration level of memory B cells, plasma cells, CD4 memory-activated T cells, macrophages M1, and activated mast cells in cluster 2, while reduced infiltration of monocytes, resting dendritic cells, and resting mast cells was captured in cluster 2. In conclusion, significant different gene expression characteristics were pooled according to the two subgroups of LUAD. The combination of subgroups, TMB and tumor-infiltrating immune cell signature, might be a novel prognostic biomarker in LUAD.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Identification and Validation of a Hypoxia and Glycolysis Prognostic Signatures in Lung Adenocarcinoma
    Zhao, Wenhao
    Ding, Chen
    Zhao, Meiru
    Li, Yongwen
    Huang, Hua
    Li, Xuanguang
    Cheng, Qian
    Shi, Zijian
    Gao, Weining
    Liu, Hongyu
    Chen, Jun
    JOURNAL OF CANCER, 2024, 15 (06): : 1568 - 1582
  • [2] Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma
    Wang, Xin
    Xu, Zhenyi
    Liu, Zhilin
    Lin, Weihao
    Cao, Zheng
    Feng, Xiaoli
    Gao, Yibo
    He, Jie
    FRONTIERS IN GENETICS, 2022, 13
  • [3] Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
    Lu, Guojun
    Shi, Wen
    Zhang, Yu
    FRONTIERS IN GENETICS, 2021, 12
  • [4] Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
    Peng, Lu-Shan
    Duan, Sai-Li
    Li, Run-Qi
    Wang, Dan
    Han, Ying-Ying
    Huang, Tao
    Yu, Yu-Pei
    Ou, Chun-Lin
    Wang, Jun-Pu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Clinical significance and immune landscape of a novel immune cell infiltration-based prognostic model in lung adenocarcinoma
    Qiu, Lupeng
    Yang, Zizhong
    Jia, Guhe
    Liang, Yanjie
    Du, Sicheng
    Zhang, Jian
    Liu, Minglu
    Zhao, Xiao
    Jiao, Shunchang
    HELIYON, 2024, 10 (12)
  • [6] Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures
    Deng, Lili
    Long, Fei
    Wang, Ting
    Dai, Ling
    Chen, Huajian
    Yang, Yujun
    Xie, Guoming
    FRONTIERS IN MEDICINE, 2022, 9
  • [7] Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
    Wang, Yuzhi
    Xu, Yunfei
    Liu, Chunyang
    Yuan, Chengliang
    Zhang, Yi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] SPOCK2 Serves as a Potential Prognostic Marker and Correlates With Immune Infiltration in Lung Adenocarcinoma
    Zhao, Jinming
    Cheng, Ming
    Gai, Junda
    Zhang, Ruochen
    Du, Tengjiao
    Li, Qingchang
    FRONTIERS IN GENETICS, 2020, 11
  • [9] Deciphering Prognostic Value of TTN and Its Correlation With Immune Infiltration in Lung Adenocarcinoma
    Chen, Jianing
    Wen, Yaokai
    Su, Hang
    Yu, Xin
    Hong, Ruisheng
    Chen, Chang
    Su, Chunxia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation
    Zhang, Tongyi
    Zhu, Liyong
    Cai, Jianhua
    He, Jiaqi
    OPEN MEDICINE, 2022, 17 (01): : 427 - 440